← Eichor
Condition: Retinal Anomalies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Retinal Anomalies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · 18 location(s) · Jaeb Center for Health Research · NCT06837181InsightRP2 Registry
Phase N/A · 1 location(s) · University of Göttingen · NCT06982417Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degener
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT06375239Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Phase 3 · 1 location(s) · Assaf-Harofeh Medical Center · NCT06067958An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
EARLY_Phase 1 · 1 location(s) · HuidaGene Therapeutics Co., Ltd. · NCT07063251Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · 8 location(s) · Ascidian Therapeutics, Inc · NCT06445322Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 · 1 location(s) · Cellio Therapeutics Inc · NCT07594236Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Caus
Phase N/A · 36 location(s) · Jaeb Center for Health Research · NCT05589714Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in
Phase N/A · 1 location(s) · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingt · NCT07278843Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
NA · 1 location(s) · Baskent University Ankara Hospital · NCT06672913(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
NA · 6 location(s) · Carl Zeiss Meditec-Dublin CoCe · NCT07680244Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
Phase N/A · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06190626Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
Phase N/A · 1 location(s) · Elazıg Fethi Sekin Sehir Hastanesi · NCT07480720Cell Collection to Study Eye Diseases
Phase N/A · 1 location(s) · National Eye Institute (NEI) · NCT01432847New Non-invasive Modalities for Assessing Retinal Structure and Function
NA · 1 location(s) · Randy Kardon · NCT03475173Retinal Imaging in Patients With Inherited Retinal Degenerations
Phase N/A · 1 location(s) · University of California, San Francisco · NCT00254605Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT06612541Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Phase 1/Phase 2 · 10 location(s) · Ascidian Therapeutics, Inc · NCT06467344Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Phase 4 · 1 location(s) · Chang Gung Memorial Hospital · NCT06520410A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years
Phase 1/Phase 2 · 2 location(s) · Sumitomo Pharma America, Inc. · NCT06891885Retina is a Marker for Cerebrovascular Heath
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT04753970Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · 3 location(s) · Ray Therapeutics, Inc. · NCT07439887Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal
Phase N/A · 1 location(s) · Ray Therapeutics, Inc. · NCT07502664A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Phase 1/Phase 2 · 8 location(s) · AAVantgarde Bio Srl · NCT07161544An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Au
Phase N/A · 20 location(s) · Splice Bio · NCT06435000Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT07065747Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Phase 1/Phase 2 · 1 location(s) · Chigenovo Co., Ltd · NCT06952842Retinal Imaging in Neurodegenerative Disease
Phase N/A · 1 location(s) · Duke University · NCT03233646Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
NA · 2 location(s) · Duke University · NCT04995341Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Phase N/A · 5 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001373
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.